What Is Postmenopausal Atrophy?

After menopause, circulating estrogen drops dramatically. Because the vagina, vulva, urethra, and bladder trigone all contain estrogen receptors, these tissues become thinner, drier, less elastic, and more fragile. The resulting cluster of symptoms is called genitourinary syndrome of menopause (GSM) — previously known as atrophic vaginitis.

GSM affects an estimated 50–70% of postmenopausal women. Unlike hot flashes, it does not improve on its own with time — it typically worsens. The good news: it responds very well to treatment.

Symptoms

Vulvovaginal Symptoms

  • Dryness and loss of natural lubrication
  • Burning, itching, or irritation
  • Painful intercourse (dyspareunia)
  • Tearing or bleeding with intercourse or exam
  • Tightening of the vaginal opening; shortening or narrowing
  • Decreased libido often secondary to discomfort

Urinary Symptoms

  • Frequency, urgency, and nighttime urination
  • Burning with urination without infection
  • Recurrent UTIs — a major driver of GSM-related visits
  • Worsening of existing urinary incontinence
  • Sensitivity or irritation at the urethra

How Is It Diagnosed?

Diagnosis is usually based on a careful history and a focused pelvic exam. Additional tests may rule out other causes of similar symptoms.

  • History — menopausal status, symptom pattern, sexual function, urinary symptoms, recurrent UTIs
  • Pelvic exam — pale, thin, less elastic tissues; loss of vaginal folds (rugae); shortening or narrowing of the vagina; petechiae or fissures
  • Urinalysis and culture — if urinary symptoms are present, to rule in or out a UTI
  • Vaginal pH — often elevated (>4.5) in GSM
  • Ruling out other conditions — such as lichen sclerosus, dermatoses, or infection

Treatment Options

Treatment is stepped: start simple, add therapies as needed, and combine approaches for the best comfort.

1. Non-Hormonal First Steps

Moisturizers and Lubricants

  • Vaginal moisturizers (e.g., hyaluronic acid, Replens, Revaree) — used 2–3 times per week to improve baseline tissue hydration
  • Lubricants (water- or silicone-based) — used during intercourse to reduce friction
  • Avoid irritants — scented soaps, douches, scented pads, tight synthetic fabrics

Regular Sexual Activity or Stimulation

Regular arousal and intercourse (with lubricant as needed) improves blood flow and preserves vaginal caliber.

2. Topical (Local) Vaginal Estrogen — First-Line Medical Therapy

For most women with bothersome GSM symptoms, topical vaginal estrogen is the most effective treatment. It is applied directly where the tissue is thin, works within a few weeks, and has minimal systemic absorption.

See our dedicated page on the benefits of topical vaginal estrogen.

Creams

Applied with an applicator 2–3 times per week after an initial daily loading period.

Tablets / Inserts

Small, mess-free vaginal tablets used 2 times per week.

Vaginal Ring

A soft ring that releases estrogen for 3 months at a time.

Topical estrogen is considered safe and effective even in women who cannot take systemic hormone therapy, including many breast cancer survivors — in close coordination with the oncology team.

3. Non-Estrogen Prescription Options

  • Ospemifene — a daily oral selective estrogen receptor modulator (SERM) for moderate to severe painful intercourse related to GSM
  • DHEA (prasterone) vaginal inserts — a daily non-estrogen insert that converts locally to active hormones
  • Vaginal hyaluronic acid — non-hormonal moisturizer with strong supporting data

4. Pelvic Floor Physical Therapy & Dilators

For women with significant vaginal tightening, sexual pain, or guarding, pelvic floor physical therapy and a graduated vaginal dilator program can safely restore caliber and comfort — typically alongside topical estrogen.

5. Systemic Hormone Therapy (Selected Cases)

For women who also have bothersome hot flashes, mood changes, or sleep disturbance, systemic hormone therapy may be considered in coordination with your primary care or gynecology team. Systemic therapy treats GSM as a byproduct, but topical estrogen is usually added if symptoms persist.

GSM & Recurrent UTIs

One of the most under-recognized benefits of treating GSM is a major reduction in recurrent urinary tract infections. Topical vaginal estrogen is endorsed by urology and urogynecology guidelines as a first-line therapy for recurrent UTIs in postmenopausal women.

Frequently Asked Questions

Is topical estrogen safe?

Yes. Topical vaginal estrogen has very low systemic absorption and is considered safe for long-term use in the vast majority of women. For specific questions, including in cancer survivors, we will coordinate with your team.

How long until I feel better?

Most women notice improvement within 2–4 weeks of starting topical estrogen, with continued benefit over 3 months.

Do I need to stay on treatment forever?

GSM is a chronic condition — symptoms return if treatment is stopped. Long-term use is safe and effective.

Will treatment help my UTIs?

Yes — topical vaginal estrogen significantly reduces recurrent UTIs in postmenopausal women.

What if my symptoms persist despite treatment?

We will reassess — confirm the diagnosis, look for coexisting conditions such as lichen sclerosus, and consider adding a second-line medication, pelvic floor PT, or dilator therapy.

Relief from Dryness, Discomfort, and UTIs

GSM is common — and it is also one of the most treatable conditions in women's health. Our team will evaluate your symptoms, rule out other causes, and build a plan that restores comfort and protects urinary and sexual health.

  • ✅ Comprehensive genitourinary evaluation
  • ✅ Topical estrogen, non-estrogen, and combination options
  • ✅ Coordinated care with your primary care and gynecology teams
  • ✅ Pelvic floor PT and dilator programs when needed
Schedule Your Consultation

Call 678-344-8900 to speak with our team